ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Renal"

  • Abstract Number: PP17 • ACR Convergence 2026

    What I Was Never Told: A Patient Perspective on Systemic Sclerosis Renal Crisis

    Falguni Desai Affiliations: Retired, Fremont

    Background/Purpose: In 2018, I began experiencing progressive weakness, swelling, fatigue, and loss of function that steadily impacted my daily life and independence. After months of…
  • Abstract Number: 0712 • ACR Convergence 2026

    Gout Flare Burden and Cardiorenal Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus and Gout: A Propensity-Matched Retrospective Study

    Rhytha Kasiraj, Vidhi Bhanushali, Arnav Lakkimsetti and Manoja Gullapalli Affiliations: University of Arkansas for Medical Sciences, Little Rock, AR

    Background/Purpose: GLP-1 receptor agonists (GLP-1 RAs) have established cardiovascular and renal benefits in T2DM and demonstrate uricosuric and anti-inflammatory properties in preclinical studies that may…
  • Abstract Number: 1263 • ACR Convergence 2026

    Early Identification of Proteinuria in Lupus: Diagnostic Performance of First Morning, Random, and 24-Hour Urine Protein Measurements

    Tamar Gilad1, Molly Atiencia-Arizaga1, Amira Eldesouky1, Themba Nyirenda2, Samuel Belony3, Kate Thomas4 and Anna Broder3 Affiliations: 1Hackensack Meridian School of Medicine, Nutley, NJ, 2Hackensack Meridian Health, Nutley, NJ, 3Hackensack Meridian Health, Hackensack, NJ, 4Hackensack University Medical Center, Hackensack, NJ

    Background/Purpose: Early detection of proteinuria can identify kidney involvement in systemic lupus erythematosus (SLE), providing an opportunity for earlier interventions to improve outcomes and survival1,2.…
  • Abstract Number: 1997 • ACR Convergence 2026

    Dysregulation of sphingosine-1-phosphate signaling in systemic lupus erythematosus and its therapeutic implications

    Xiaoyu Chen1 and Chun Li2 Affiliations: 1Peking University People's Hospital, Department of Rheumatology and Immunology, Beijing, China (People's Republic), 2Peking University People's Hospital, Department of Rheumatology and Immunology, Beijing, Beijing, China (People's Republic)

    Background/Purpose:  The etiology of systemic lupus erythematosus (SLE) remains incompletely understood, and current therapies largely rely on broad-spectrum immunosuppressants. Sphingosine-1-phosphate (S1P) is a bioactive lipid…
  • Abstract Number: 0713 • ACR Convergence 2026

    Gout in Advanced Chronic Kidney Disease: High Prevalence, Low Target Attainment, and Association with Mortality – Real-World Evidence for a Complex Comorbidity

    Romika Subedi1, Ayub Akbari2, Timothy Kowk3, Cedric Edwards2 and Priyanka Chandratre4 Affiliations: 1Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, 2Department of Medicine, Division of Nephrology, The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada, 3Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 4Department of Medicine, Division of Rheumatology, The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Background/Purpose: Gout is common in advanced chronic kidney disease (CKD), yet evidence guiding urate-lowering therapy (ULT) in this population remains limited. Challenges include impaired renal…
  • Abstract Number: 1267 • ACR Convergence 2026

    Histological Evolution and Clinical Impact of Repeat Renal Biopsy in Lupus Nephritis

    Sriyanka Mohapatra1, Ritesh Kumar Mishra2, Mohammed Razeen KM3, Gadila Sindhu Reddy4, Mani Rajendran5, Rizwana Naushad6, Subin Philip7, Christina Mary Marialselvam8, Molly Thabah3 and VS Negi3 Affiliations: 1Jawaharlal Institute of Postgraduate Education and Research, Puducherry, Tamil Nadu, India, 2JIPMER, Puducherry, Puducherry, Puducherry, India, 3Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, Puducherry, India, 4Jawaharlal Institute of Postgraduate Education and Research, Puducherry, India, 5JIPMER, Puducherry, Puducherry, India, 6Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, Puducherry, Puducherry, India, 7JIPMER , PUDUCHERRY, Kottayam, Kerala, India, 8Jawaharlal Institute of Postgraduate Education and Research, Puducherry, Puducherry, India

    Background/Purpose: Lupus nephritis shows temporal heterogeneity in histological class and chronic damage, often independent of clinical and laboratory parameters [1]. We evaluated histological class transitions,…
  • Abstract Number: 2000 • ACR Convergence 2026

    Inflammation-independent Remodeling Defines a Renal Disease Axis in Systemic Lupus Erythematosus

    Ryan Stultz1, Divya Ravichandar2, Peirou Chou2, Natasha Crellin2, Ching Shang3 and Christian Lood1 Affiliations: 1University of Washington, Seattle, WA, 2Gilead, Foster City, CA, 3Gilead Sciences, Foster City, CA

    Background/Purpose: Renal involvement in systemic lupus erythematosus (SLE) is heterogeneous, and mechanisms underlying renal injury extend beyond canonical interferon-driven inflammation. We hypothesized that remodeling-associated biology…
  • Abstract Number: 0923 • ACR Convergence 2026

    The Disparate Effect of Statins on eGFR in Systemic Lupus Erythematosus

    Faith Obilo1, Andrea Fava1, Daniel Goldman2, Laurence Magder3 and Michelle Petri2 Affiliations: 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University School of Medicine, Timonium, MD, 3University of Maryland, Baltimore, Baltimore, MD

    Background/Purpose: Beyond lipid-lowering, statins may preserve kidney function through anti-inflammatory effects, improved endothelial function, and reduced podocyte cell death. The 2024 KDIGO guidelines recommend statins…
  • Abstract Number: 1285 • ACR Convergence 2026

    Renal Tubular Complement C9 Deposition is Linked to Tubulointerstitial Fibrosis and Progression to Chronic Kidney Disease in Lupus Nephritis: a two-center study.

    Akshay Kelshiker1, Angela Lu1, Daming Shao2, Xianhong Xie3, James Pullman4, Luis Chiriboga5, H Michael Belmont6 and Shudan Wang7 Affiliations: 1Albert Einstein College of Medicine, Bronx, 2Division of Rheumatology, University of Chicago Medical Center, Chicago, 3Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, 4Department of Pathology, Montefiore Medical Center, Bronx, 5Department of Pathology, New York University Medical Center, New York City, 6NYU Grossman School of Medicine, New York, 7Montefiore Medical Center / Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Lupus nephritis (LN) is a major cause of chronic kidney disease (CKD) and end-stage renal disease in systemic lupus erythematosus. Emerging data suggest that intrarenal complement…
  • Abstract Number: 2131 • ACR Convergence 2026

    Clinical Outcomes by Glucocorticoid Duration in Individuals with Granulomatosis with Polyangiitis and Microscopic Polyangiitis Treated with Avacopan in a Real-World Setting in Two Large Healthcare Systems

    Naomi Patel1, Brian Jaros2, Andrew King3, Madison Negron4, Ana Fernandes5, Zachary Williams4, John Seagrist6, Ruth Misha6, Nora Shepherd7, Colebrooke Johnson4, Bohang Jiang8, Guy Katz1, Belen Arevalo1, Elizabeth Ibiloye9, Phuong Pham10, Alana Bozeman11, Zachary Wallace12, Anisha Dua13 and Sebastian Unizony14 Affiliations: 1Massachusetts General Hospital, Boston, MA, 2Northwestern University - Feinberg School of Medicine, Chicago, IL, 3Massachusetts General Hospital, Boston, 4MGH, Boston, 5Medical School Candidate, Boston, MA, 6Northwestern, Chicago, 7George Washington University, Boston, MA, 8MGH, Boston, MA, 9Amgen Inc, Thousand Oaks, CA, 10Amgen, Sudbury, MA, 11Amgen Inc., Thousand Oaks, CA, 12Amgen, Newton, MA, 13Northwestern University, Chicago, IL, 14Massachusetts General Hospital / Harvard Medical School, Winchester, MA

    Background/Purpose: The ADVOCATE trial that led to the approval of avacopan for the treatment of severe active granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)…
  • Abstract Number: 0933 • ACR Convergence 2026

    Microvascular Antiphospholipid Syndrome Is Associated with Subclinical Renal Involvement and Long-Term Kidney Function Decline

    Oshrat Tayer-Shifman1, Naama Gvilli2, Osnat Jarchowsky Dolberg2, Yael Pri-Paz Basson3, shaye Kivity4 and Keren Cohen-Hagai2 Affiliations: 1Meir Medical Center, Ra'anana, Israel, 2Meir Medical Center, Kfar Saba, Israel, 3meir hospital, Zur Moshe, Israel, 4Meir medical center, Ramat Gan, Israel

    Background/Purpose: Renal involvement in antiphospholipid syndrome (APS) may be under-recognized, particularly in patients without overt renal thrombosis or severe reduction in estimated glomerular filtration rate…
  • Abstract Number: 1298 • ACR Convergence 2026

    Urinary Complement Activation Products and Soluble CD163 as Lupus Nephritis Biomarkers

    Sajida Alkadri1, Miriam Li1, Daniel Muruve1, Antoine Dufour1, Marinka Twilt2, Yvan St. Pierre3, Ashley Clarke1, Paul Sciore4, Marvin Fritzler5 and May Choi6 Affiliations: 1University of Calgary, Calgary, Canada, 2Alberta Children's Hospital, Calgary, AB, Canada, 3Research Institute of the McGill University Health Center, Montreal, QC, Canada, 4MitogenDx, Calgary, AB, Canada, 5Mitogen Diagnostics Corp, Calgary, AB, Canada, 6University of Calgary, Calgary, AB, Canada

    Background/Purpose: The gold standard for diagnosing lupus nephritis (LN) is renal biopsy, an invasive procedure with associated risks. While traditional biomarkers such as proteinuria and…
  • Abstract Number: 2139 • ACR Convergence 2026

    Neighborhood Deprivation as a Risk Factor for Progression to End-Stage Kidney Disease in ANCA-Associated Vasculitis: Experiences from a Large Rural Tertiary Care Rheumatology Referral Center

    Kirsten Fiestan1, Bharat Kumar2, Melissa Swee1 and Gatr-alnada Gheriani1 Affiliations: 1University of Iowa Hospital and clinics, Iowa city, IA, 2University of Iowa Hospitals and Clinics, Iowa City, IA

    Background/Purpose: ANCA-associated vasculitis (AAV) is a systemic rheumatic disease whose morbidity is dominated by irreversible organ damage. While racial and ethnic disparities in AAV outcomes…
  • Abstract Number: 1007 • ACR Convergence 2026

    Non-Responder Status and Biopsy Chronicity in Lupus Nephritis Associate with Markers of Senescence and Hypoxia Across Kidney Cell Types

    Maya Shumyatcher1, Jennifer Nicholson2, Nida Meednu3, Arpitha Haranahalli Shivarudrappa2, RuoQiao Wang3, Javier Rangel-Moreno3, Juilee Thakar3, Jennifer Barnas3 and Jennifer Anolik4 Affiliations: 1University of Rochester Medical Center/Strong Memorial Hospital, Rochester, 2University of Rochester, Rochester, 3University of Rochester, Rochester, NY, 4University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Lupus nephritis (LN) is a severe and common complication of systemic lupus erythematosus (SLE), associated with worse long-term outcomes and increased mortality. Despite current…
  • Abstract Number: 1439 • ACR Convergence 2026

    Disease activity and long-term kidney function trajectories in rheumatoid arthritis: a Japanese nationwide registry cohort study using the NinJa database

    Hiroshi Kajiyama1, Yukiko Oya2, Maiko Osawa3, Yuki Shiko3, Hisashi Noma4, Yoshimi Aizaki1, Kazuhiro Yokota1, Yasuto Araki1, Toshihiro Matsui5, Shigeto Tohma6, Yuji Akiyama1 and Toshihide Mimura7 Affiliations: 1Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Iruma-gun, Saitama, Japan, 2Research Administration Center, Saitama Medical University, Iruma-gun, Saitama, Japan, 3Department of Biostatistics, Graduate School of Medicine, Saitama Medical University, Iruma-gun, Saitama, Japan, 4The Institute of Statistical Mathematics, Tachikawa city, Tokyo, Japan, 5National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan, 6National Hospital Organization Tokyo National Hospital, Kiyose, Tokyo, Japan, 7Saitama Seikei Hospital, Higashimatsuyama, Saitama, Japan

    Background/Purpose: Previous studies from the United States and Taiwan have shown that patients with rheumatoid arthritis (RA) have a higher risk of developing chronic kidney…
  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology